Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions
Abstract
In this postmortem study, we investigated the relationship between multiple sclerosis (MS) lesions in the hypothalamus and the state of activity of corticotropin-releasing hormone (CRH)-producing neurons that control the hypothalamus-pituitary-adrenal (HPA) axis. A high incidence (15/16) of MS lesions was found in the hypothalamus, of which more than 50% was active, that is, contained activated macrophages. MS patients have increased numbers of CRH-immunoreactive neurons coexpressing vasopressin (CRH/VP neurons), a sign of chronic activation of CRH neurons and increased CRH mRNA expression. Active MS lesions correlated with a low number of hyperactive CRH/VP neurons. High human leukocyte antigen (HLA)-DR, -DP, -DQ expression, a measure for macrophage and microglial activation, correlated with low CRH mRNA expression. The nearer the HLA expression was situated to the CRH neurons, the stronger the inhibiting effect, suggesting that activated microglial cells or macrophages suppress these neurons. The more active MS lesions were present in the hypothalamus, the shorter was the disease duration until the moment of death, indicating an unfavorable course of the disease. Thus, MS patients have a chronically activated CRH system, but, in the subgroup of patients with active MS lesions in the hypothalamus, this activation is impaired and the disease course is worse.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Neuropathological studies reported a high proportion of patients with inflammatory and demyelinating lesions of the hypothalamus, with indices of altered HPA activity.
“Additionally, neuropathological studies reported a high proportion of patients with inflammatory and demyelinating lesions of the hypothalamus, with indices of altered HPA activity (Huitinga et al., 2001, 2004).”
From Allostatic Self-efficacy: A Metacognitive Theory of Dyshomeostasis-Induced Fatigue and Depression (2016) · cites this paper as Huitinga et al., 2004
Cites
Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
TURNBULL, A. V., & RIVIER, C. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.1 · Cited by 1,297 · see citing works
Handbook of chemical neuroanatomy
(2005) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(05)80001-6 · Cited by 906 · see citing works
Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system
Whitnall, M. H. (1993) · Progress in Neurobiology · doi:10.1016/0301-0082(93)90035-q · Cited by 582 · see citing works
Raadsheer, F. C., van Heerikhuize, J. J., Lucassen, P. J., Hoogendijk, W. J. G., Tilders, F. J. H., & Swaab, D. F. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1372 · Cited by 411 · see citing works
Self-citationMacPhee, I. A., Antoni, F. A., & Mason, D. W. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.2.431 · Cited by 328 · see citing works
Electrically active axons degenerate when exposed to nitric oxide
Smith, K. J., Kapoor, R., Hall, S. M., & Davies, M. (2001) · Annals of Neurology · doi:10.1002/ana.96 · Cited by 320 · see citing works
Groot, C. J. A. D. (2001) · Brain · doi:10.1093/brain/124.8.1635 · Cited by 285 · see citing works
Cytokine localization in multiple sclerosis lesions
Brosnan, C. F., Cannella, B., Battistini, L., & Raine, C. S. (1995) · Neurology · doi:10.1212/wnl.45.6_suppl_6.s16 · Cited by 202 · see citing works
Miller, D. H., Thompson, A. J., Morrissey, S., MacManus, D. G., Moore, S. G., Kendall, B. E., MOSELEY, I. F., & McDonald, W. I. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.6.450 · Cited by 188 · see citing works
Multiple sclerosis is associated with alterations in hypothalamic- pituitary-adrenal axis function
Michelson, D., Stone, L., Galliven, E., Magiakou, M. A., Chrousos, G. P., Sternberg, E. M., & Gold, P. W. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.3.8077372 · Cited by 178 · see citing works
Corticotropin‐Releasing Hormone and Inflammation
WEBSTER, E. L., Torpy, D. J., Elenkov, I. J., & Chrousos, G. P. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09545.x · Cited by 177 · see citing works
The neuroendocrine axis in patients with multiple sclerosis
Wei, T. C. (1997) · Brain · doi:10.1093/brain/120.6.1067 · Cited by 163 · see citing works
Poser, C. M., Chaudhuri, A., Behan, P. O., Lehrer, G. M., & Goodin, D. (2000) · Neurology · doi:10.1212/wnl.54.6.1393 · Cited by 121 · see citing works
Hypothalamic lesions in multiple sclerosis
Huitinga, I., De Groot, C. J. A., Van der Valk, P., Kamphorst, W., Tilders, F. J. H., & Swaab, D. F. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.12.1208 · Cited by 120 · see citing works
Self-citationThe relationship of MS to physical trauma and psychological stress [RETIRED]
Goodin, D. S., Ebers, G. C., Johnson, K. P., Rodriguez, M., Sibley, W. A., & Wolinsky, J. S. (1999) · Neurology · doi:10.1212/wnl.52.9.1737 · Cited by 115 · see citing works
Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS
Bergh, F. T., Kümpfel, T., Trenkwalder, C., Rupprecht, R., & Holsboer, F. (1999) · Neurology · doi:10.1212/wnl.53.4.772 · Cited by 112 · see citing works
CR3/43, a marker for activated human microglia: application to diagnostic neuropathology
Graeber, M. B., Bise, K., & Mehraein, P. (1994) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1994.tb00987.x · Cited by 89 · see citing works
Adrenal Size Is Increased in Multiple Sclerosis
Reder, A. T., Makowiec, R. L., & Lowy, M. T. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540140057015 · Cited by 89 · see citing works
Drug treatment of multiple sclerosis
Polman, C. H. (2000) · Western Journal of Medicine · doi:10.1136/ewjm.173.6.398 · Cited by 84 · see citing works
Heesen, C., Gold, S. M., Raji, A., Wiedemann, K., & Schulz, K. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00071-3 · Cited by 81 · see citing works
Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis
Erkut, Z. A., Hofman, M. A., Ravid, R., & Swaab, D. F. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00098-m · Cited by 79 · see citing works
Self-citationGrasser, A., Möller, A., Backmund, H., et al. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211419 · Cited by 71 · see citing works
Adrenal functions in patients with sepsis *
Aygen, B., Inan, M., Doğanay, M., & Keleştimur, F. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211749 · Cited by 67 · see citing works
Schumann, E. M., Kümpfel, T., Bergh, F. T., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10187 · Cited by 62 · see citing works
Chemokine Receptors and Neural Function
Cho, C., & Miller, R. J. (2002) · Journal of NeuroVirology · doi:10.1080/13550280290101003 · Cited by 59 · see citing works
Dexamethasone suppression test abnormalities in multiple sclerosis
Reder, A. T., Lowy, M. T., Meltzer, H. Y., et al. (1987) · Neurology · doi:10.1212/wnl.37.5.849 · Cited by 57 · see citing works
Regular review: Drug treatment of multiple sclerosis
Polman, C. H. (2000) · BMJ · doi:10.1136/bmj.321.7259.490 · Cited by 57 · see citing works
IL-1β immunoreactive neurons in the human hypothalamus: reduced numbers in multiple sclerosis
Huitinga, I., van der Cammen, M., Salm, L. P., Erkut, Z. A., van Dam, A., Tilders, F. J. H., & Swaab, D. F. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00248-4 · Cited by 53 · see citing works
Self-citationErkut, Z. A., Endert, E., Huitinga, I., & Swaab, D. F. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms797oa · Cited by 48 · see citing works
Self-citationStefferl, A., Storch, M. K., Linington, C., Stadelmann, C., Lassmann, H., Pohl, T., Holsboer, F., Tilders, F. J. H., & Reul, J. M. H. M. (2001) · Endocrinology · doi:10.1210/endo.142.8.8292 · Cited by 46 · see citing works
Lucassen, P. J., Goudsmit, E., Pool, C. W., Mengod, G., Palacios, J. M., Raadsheer, F. C., Guldenaar, S. E. F., & Swaab, D. F. (1995) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)00152-7 · Cited by 38 · see citing works
Self-citationTrauma, stress and multiple sclerosis
Martinelli, V. (2000) · Neurological Sciences · doi:10.1007/s100720070024 · Cited by 33 · see citing works
Mood Disorders and Dysfunction of the Hypothalamic-Pituitary-Adrenal Axis in Multiple Sclerosis
Fassbender, K. C., Schmidt, R., Mößner, R., Kischka, U., Kühnen, J., Schwartz, A., & Hennerici, M. G. (1998) · Archives of Neurology · doi:10.1001/archneur.55.1.66
Flagged first, then by citations
Cited by
Sorted by citations
Allostatic Self-efficacy: A Metacognitive Theory of Dyshomeostasis-Induced Fatigue and Depression
Stephan, K. E., Manjaly, Z. M., Mathys, C. D., Weber, L. A. E., Paliwal, S., Gard, T., Tittgemeyer, M., Fleming, S. M., Haker, H., Seth, A. K., et al. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00550 · Cited by 437 · see citing works
“Frontiers in Human Neuroscience | www.frontiersin.org 18 November 2016 | Volume 10 | Article 550 reported a high proportion of patients with inflammatory and demyelinating lesions of the hypothalamus, with indices of altered HPA activity (Huitinga et al., 2001, 2004).”
BackgroundPetzschner, F. H., Weber, L. A. E., Gard, T., & Stephan, K. E. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.012 · Cited by 181 · see citing works
Patejdl, R., Penner, I. K., Noack, T. K., & Zettl, U. K. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.11.005 · Cited by 141 · see citing works
Harpaz, I., Abutbul, S., Nemirovsky, A., Gal, R., Cohen, H., & Monsonego, A. (2013) · European Journal of Immunology · doi:10.1002/eji.201242613 · Cited by 64 · see citing works
Magnocellular hypothalamic system and its interaction with the hypothalamo-pituitary-adrenal axis
Sivukhina, E. V., & Jirikowski, G. F. (2016) · Steroids · doi:10.1016/j.steroids.2016.01.008 · Cited by 29 · see citing works
Fatigue: Pharmacological and non-pharmacological management in patients with multiple sclerosis
Yeni, K. (2024) · Advanced Neurology · doi:10.36922/an.2576 · Cited by 2 · see citing works
- Authors
- Huitinga, I., Erkut, Z. A., van Beurden, D., & Swaab, D. F.
- Affiliations
- Royal Netherlands Academy of Arts and Sciences (NL)
- Corresponding author
- Huitinga, Inge
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2003-12
- Volume
- 55
- Issue
- 1
- Pages
- 37-45
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2125763025
- Cited by
- 126
- References
- 33
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 8 · 2022: 5 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 9 · 2017: 4 · 2016: 8 · 2015: 6 · 2014: 6 · 2013: 8 · 2012: 5
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- multiple sclerosis, hypothalamus, hypothalamic-pituitary-adrenal axis, corticotropin-releasing factor, HLA class II expression, macrophage activation, microglial activation, lesion activity, disease duration, postmortem brain
- MeSH terms
- Adult, Aged, Aged, 80 and over, Corticotropin-Releasing Hormone, Female, HLA Antigens, Humans, Hypothalamo-Hypophyseal System, Hypothalamus, Image Processing, Computer-Assisted, Immunohistochemistry, Macrophage Activation, Male, Middle Aged, Multiple Sclerosis, Neurons, Pituitary-Adrenal System, RNA, Messenger, Vasopressins, In Situ Hybridization, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review